The meningococcal ABC-type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice

Infection and Immunity

Volumn 77, Issue 9, 2009, Pages 3578-3587

  Colicchio, Roberta ^a   Ricci, Susanna ^b   Lamberti, Florentia ^c   Pagliarulo, Caterina ^d   Pagliuca, Chiara ^c   Braione, Velia ^b   Braccini, Tiziana ^b   Talà, Adelfia ^e   Montanaro, Donatella ^f   Tripodi, Sergio ^b   Cintorino, Marcella ^b   Troncone, Giancarlo ^c,f   Bucci, Cecilia ^e   Pozzi, Gianni ^b   Bruni, Carmelo B ^c,f   Alifano, Pietro ^e   Salvatore, Paola ^c  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF SANNIO   (Italy)

^e UNIVERSITY OF SALENTO   (Italy)

^f CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE TRANSPORTER; PROTEIN GLTT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDEMIC MENINGITIS; HOST PATHOGEN INTERACTION; MIXED INFECTION; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; VIRULENCE;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; FEMALE; GLUTAMIC ACID; MENINGITIS, MENINGOCOCCAL; MICE; NEISSERIA MENINGITIDIS; VIRULENCE;

EID: 69049091991     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01424-08     Document Type: Article

References (60)

1. Alonso, J. M., A. Guiyoule, M. L. Zarantonelli, F. Ramisse, R. Pires, A. Antignac, A. E. Deghmane, M. Huerre, S. van der Werf, and M. K. Taha. 2003. A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol. Lett. 222:99-106.
2. Auerbuch, V., L. L. Lenz, and D. A. Portnoy. 2001. Development of a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice. Infect. Immun. 69:5953-5957.
3. Beuzón, C. R., and D. W. Holden. 2001. Use of mixed infections with Salmonella strains to study virulence genes and their interaction in vivo. Microbes Infect. 3:1345-1352.
4. Brandtzaeg, P., A. Halstensen, P. Kierulf, T. Espevik, and A. Waage. 1992. Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb. Pathog. 13:423-431.
5. Brandtzaeg, P., and M. van Deuren. 2002. Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr. Opin. Infect. Dis. 15:247-252.
6. Bucci, C., A. Lavitola, P. Salvatore, L. Del Giudice, D. R. Massardo, C. B. Bruni, and P. Alifano. 1999. Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol. Cell 3:435-445.
7. Chiavolini, D., S. Tripodi, R. Parigi, M. R. Oggioni, E. Blasi, M. Cintorino, G. Pozzi, and S. Ricci. 2004. Method for inducing experimental pneumococcal meningitis in outbred mice. BMC Microbiol. 4:36.
8. Colucci, A. M., B. Peracino, A. Talà, S. Bozzaro, P. Alifano, and C. Bucci. 2008. Dictyostelium discoideum as a model host for meningococcal pathogenesis. Med. Sci. Monit. 14:BR134-BR140.
9. de Vries, F. P., A. van Der Ende, J. P. van Putten, and J. Dankert. 1996. Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect. Immun. 64:2998-3006.
10. Flexner, S. 1907. Experimental cerebrospinal meningitis in monkeys. J. Exp. Med. 9:142-166.
11. Frosch, M., E. Schultz, E. Glenn-Calvo, and T. F. Meyer. 1990. Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination. Mol. Microbiol. 4:1215-1218.
12. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
13. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
14. Gorringe, A. R., K. M. Reddin, S. G. Funnell, L. Johansson, A. Rytkönen, and A. B. Jonsson. 2005. Experimental disease models for the assessment of meningococcal vaccines. Vaccine 23:2214-2217.
15. Guerra-Romero, L., J. H. Tureen, M. A. Fournier, V. Makrides, and M. G. Täuber. 1993. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr. Res. 33:510-513.
16. Hill, J. C. 1971. Effect of glutamate on exogenous citrate catabolism of Neisseria meningitidis and of other species of Neisseria. J. Bacteriol. 106:819-823.
17. Holbein, B. E., K. W. Jericho, and G. C. Likes. 1979. Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology. Infect. Immun. 24:545-551.
18. Johansson, L., A. Rytkonen, P. Bergman, B. Albiger, H. Källström, T. Hökfelt, B. Agerberth, R. Cattaneo, and A. B. Jonsson. 2003. CD46 in meningococcal disease. Science 301:373-375.
19. Kieseier, B. C., R. Paul, U. Koedel, T. Seifert, J. M. Clements, A. J. Gearing, H. W. Pfister, and H. P. Hartung. 1999. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122:1579-1587.
20. Koedel, U., R. Paul, F. Winkler, S. Kastenbauer, P. L. Huang, and H. W. Pfister. 2001. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 60:1041-1050.
21. Kolarova, A., R. Ringer, M. G. Täuber, and S. L. Leib. 2003. Blockade of NMDA receptor subtype NR2B prevents seizures but not apoptosis of dentate gyrus neurons in bacterial meningitis in infant rats. BMC Neurosci. 4:21.
22. Larson, J. A., H. L. Howie, and M. So. 2004. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 53:807-820.
23. Leib, S. L., Y. S. Kim, D. M. Ferriero, and M. G. Täuber. 1996. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J. Infect. Dis. 173:166-171.
24. Lentner, C. 1981. Geigy scientific tables, vol. 1. Units of measurements, body fluids, composition of the body, nutrition. Ciba-Geigy Ltd, Basel, Switzerland.
25. Lentner, C. 1984. Geigy scientific tables, vol. 3. Physical chemistry, composition of the blood, hematology, somatometric data. Ciba-Geigy Ltd, Basel, Switzerland.
26. Letendre, E. D., and B. E. Holbein. 1984. Mechanism of impaired iron release by the reticuloendothelial system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect. Immun. 44:320-325.
27. Li, M. S., N. Y. Chow, S. Sinha, D. Halliwell, M. Finney, A. R. Gorringe, M. W. Watson, J. S. Kroll, P. R. Langford, and S. A. Webb. 2009. A Neisseria meningitidis NMB1966 mutant is impaired for invasion of respiratory epithelial cells, survival in human blood and for virulence in vivo. Med. Microbiol. Immunol. 198:57-67.
28. Mackinnon, F. G., A. R. Gorringe, S. G. Funnell, and A. Robinson. 1992. Intranasal infection of infant mice with Neisseria meningitidis. Microb. Pathog. 12:415-420.
29. Mackinnon, F. G., R. Borrow, A. R. Gorringe, A. J. Fox, D. M. Jones, and A. Robinson. 1993. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb. Pathog. 15:359-366.
30. Monaco, C., A. Talà, M. R. Spinosa, C. Progida, E. De Nitto, A. Gabello, C. B. Bruni, C. Bucci, and P. Alifano. 2006. Identification of a meningococcal L-glutamate ABC transporter operon essential for growth in low-sodium environments. Infect. Immun. 74:1725-1740.
31. Morawietz, G., C. Ruehl-Fehlert, B. Kittel, A. Bube, K. Keane, S. Halm, A. Heuser, J. Hellmann, et al. 2004. Revised guides for organ sampling and trimming in rats and mice, part 3. Exp. Toxicol. Pathol. 55:433-449.
32. Nau, R. 2003. Pathophysiology of neuronal injury in bacterial meningitis: concepts and implications. Neurologia 18:47-53.
33. Newcombe, J., L. J. Eales-Reynolds, L. Wootton, A. R. Gorringe, S. G. Funnell, S. C. Taylor, and J. J. McFadden. 2004. Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity. Infect. Immun. 72:338-344.
34. Oftung, F., M. Lovik, S. R. Andersen, L. O. Froholm, and G. Bjune. 1999. A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination. FEMS Immunol. Med. Microbiol. 26:75-82.
35. Pagliarulo, C., P. Salvatore, L. R. De Vitis, R. Colicchio, C. Monaco, M. Tredici, A. Talà, M. Bardaro, A. Lavitola, C. B. Bruni, and P. Alifano. 2004. Regulation and differential expression of gdhA encoding NADP-specific glutamate dehydrogenase in Neisseria meningitidis clinical isolates. Mol. Microbiol. 51:1757-1772.
36. Plant, L., and A. B. Jonsson. 2003. Contacting the host: insights and implications of pathogenic Neisseria cell interactions. Scand. J. Infect. Dis. 35:608-613.
37. Salit, I. E., and L. Totality. 1984. Experimental meningococcal infection in neonatal mice: differences in virulence between strains isolated from human cases and carriers. Can. J. Microbiol. 30:1042-1045.
38. Salit, I. E., and L. Tomalty. 1986. A neonatal mouse model of meningococcal disease. Clin. Investig. Med. 9:119-123.
39. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Saukkonen, K. 1988. Experimental meningococcal meningitis in the infant rat. Microb. Pathog. 4:203-211.
41. Saukkonen, K., M. Leinonen, H. Abidillahi, and J. T. Poolman. 1989. Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7:325-328.
42. Schryvers, A. B., and G. C. Gonzalez. 1989. Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infect. Immun. 57:2425-2429.
43. Schryvers, A. B., and I. Stojiljkovic. 1999. Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32:1117-1123.
44. Sellner, J., R. Ringer, P. Baumann, M. J. Perey, B. Schmitt, and S. L. Leib. 2008. Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis. Curr. Drug Metab. 9:83-88.
45. Siegel, S. 1956. Nonparametric statistic for behavioral science. McGraw-Hill Book Co., New York, NY.
46. Simberkoff, M. S., N. H. Moldover, and J. Jr Rahal. 1980. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. A regional host defense deficiency. J. Lab. Clin. Med. 95:362-372.
47. Smith, H., and B. Bannister. 1973. Cerebrospinal-fluid immunoglobulins in meningitis. Lancet ii:591-593.
48. Spinosa, M. R., C. Progida, A. Talà, L. Cogli, P. Alifano, and C. Bucci. 2007. The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect. Immun. 7:3594-3603.
49. Spranger, M., S. Krempien, S. Schwab, M. Maiwald, K. Bruno, and W. Hacke. 1996. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J. Neurol. Sci. 143:126-131.
50. Spranger, M., S. Schwab, S. Krempien, M. Winterholler, T. Steiner, and W. Hacke. 1996. Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch. Neurol. 53:992-996.
51. Sun, Y. H., S. Bakshi, R. Chalmers, and C. M. Tang. 2000. Functional genomics of Neisseria meningitidis pathogenesis. Nat. Med. 6:1269-1273.
52. Talà, A., M. De Stefano, C. Bucci, and P. Alifano. 2008. Reverse transcriptase-PCR differential display analysis of meningococcal transcripts during infection of human cells: up-regulation of priA and its role in intracellular replication. BMC Microbiol. 8:131.
53. Talà, A., C. Progida, M. De Stefano, L. Cogli, M. R. Spinosa, C. Bucci, and P. Alifano. 2008. The HrpB-HrpA two-partner secretion system is essential for intracellular survival of Neisseria meningitidis. Cell. Microbiol. 10:2461-2482.
54. Tinsley, C. R., and J. E. Heckels. 1986. Variation in the expression of pili and outer membrane protein by Neisseria meningitidis during the course of the meningococcal infection. J. Gen. Microbiol. 132:2483-2490.
55. Trampuz, A., A. Steinhuber, M. Wittwer, and S. L. Leib. 2007. Rapid diagnosis of experimental meningitis by bacterial heat production in cerebrospinal fluid. BMC Infect. Dis. 7:116.
56. Tuomanen, E. I., K. Saukkonen, S. Sande, C. Cioffe, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170:959-969.
57. van Deuren, M., P. Brandtzaeg, and J. W. van der Meer. 2000. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13:144-166.
58. Virji, M., K. Makepeace, D. J. Ferguson, and S. M. Watt. 1996. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol. Microbiol. 22:941-950.
59. Welsch, J. A., G. R. Moe, R. Rossi, J. Adu-Bobie, R. Rappuoli, and D. M. Granoff. 2003. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteraemia in the absence of complement-mediated bactericidal activity. J. Infect. Dis. 188:1730-1740.
60. Zarantonelli, M. L., M. Szatanik, D. Giorgini, E. Hong, M. Huerre, F. Guillou, J. M. Alonso, and M. K. Taha. 2007. Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect. Immun. 75:5609-5614.